Yu-Cheng Kuo Selected Research

Yu-Cheng Kuo Research Topics

Disease

23	Neoplasms (Cancer) 10/2023 - 03/2005
13	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 03/2005
4	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
4	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2018
3	Body Weight (Weight, Body) 02/2023 - 01/2018
3	Neuroinflammatory Diseases 03/2019 - 11/2014
2	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 01/2023
2	Squamous Cell Carcinoma of Head and Neck 06/2023 - 01/2010
2	Disease Progression 01/2023 - 03/2019
2	Carcinogenesis 10/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 02/2012
2	Liver Neoplasms (Liver Cancer) 12/2016 - 04/2014
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2015 - 03/2005
1	Dyslipidemias (Dyslipidemia) 02/2023
1	Diabetes Complications 02/2023
1	Hyperglycemia 02/2023
1	Glioma (Gliomas) 01/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Diabetes Mellitus 01/2023
1	Adenocarcinoma 02/2022
1	Rectal Neoplasms (Rectal Cancer) 02/2022
1	Infections 01/2022
1	COVID-19 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Cholangiocarcinoma 10/2021
1	Brain Neoplasms (Brain Tumor) 04/2021
1	Ischemia 03/2019
1	Glaucoma 03/2019

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2017
5	amentoflavoneIBA 05/2022 - 09/2017
5	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 02/2012
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 02/2012
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 10/2023 - 01/2023
2	Cyclin D1IBA 01/2023 - 01/2017
2	NF-kappa B (NF-kB)IBA 01/2023 - 01/2022
2	lenvatinibIBA 05/2022 - 01/2022
2	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2021
2	regorafenibIBA 01/2022 - 01/2018
2	Neuroprotective AgentsIBA 01/2019 - 01/2013
2	thiazolyl blueIBA 05/2018 - 01/2017
1	GoldIBA 10/2023
1	Bevacizumab (Avastin)FDA Link 07/2023
1	Monoclonal AntibodiesIBA 07/2023
1	Cisplatin (Platino)FDA LinkGeneric 06/2023
1	CreatinineIBA 02/2023
1	2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA 02/2023
1	oxidized low density lipoproteinIBA 02/2023
1	Alanine (L-Alanine)FDA Link 02/2023
1	Alanine Transaminase (SGPT)IBA 02/2023
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 02/2023
1	AntioxidantsIBA 02/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2023
1	Blood Glucose (Blood Sugar)IBA 02/2023
1	CholesterolIBA 02/2023
1	Uric Acid (Urate)IBA 02/2023
1	Urea (Carbamide)FDA LinkGeneric 02/2023
1	Triglycerides (Triacylglycerol)IBA 02/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2023
1	Insulin (Novolin)FDA Link 02/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2023
1	NitrogenIBA 02/2023
1	HDL LipoproteinsIBA 02/2023
1	LDL CholesterolIBA 02/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	CateninsIBA 01/2023
1	IsotopesIBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2022
1	QuinolonesIBA 01/2022
1	Protein Kinase C-deltaIBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Cell Cycle ProteinsIBA 01/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021
1	DNA TopoisomerasesIBA 01/2021
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2021
1	astragaloside AIBA 03/2020
1	CytokinesIBA 03/2019
1	2,3,7,7a- tetrahydro- 3- hydroxy- 7- methyl- 2- (prop- 1- en- 1- yl)- 5H- furo(3,4- b)pyran- 5- oneIBA 03/2019
1	Retinaldehyde (Retinal)IBA 03/2019

Therapy/Procedure

10	Therapeutics 10/2023 - 12/2006
8	Radiotherapy 02/2022 - 03/2005
4	Drug Therapy (Chemotherapy) 07/2023 - 01/2021
3	Chemoradiotherapy 10/2023 - 01/2022
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2013 - 12/2006
2	Surgical Instruments (Clip) 12/2016 - 04/2014
1	Oral Administration 10/2023
1	Sphygmomanometers 01/2023
1	Esophagectomy 01/2022
1	Boron Neutron Capture Therapy 04/2021
1	Image-Guided Radiotherapy 01/2021
1	Adjuvant Radiotherapy 01/2021